NEW YORK – German infectious disease diagnostics startup Noscendo said on Thursday that it has raised an undisclosed amount of funding in a Series A financing round.
Participants in the round included existing investors Wieland Capital and High-Tech Gründerfonds and new investors Earlybird, Paua Ventures, and JIH Family Office.
Noscendo plans to use the funding to expand its business, hiring a CSO and a chief operating officer and launching its Disqver bioinformatics platform for the detection of cell-free pathogen DNA in blood in Europe.